tiprankstipranks
Metagenomi, Inc. (MGX)
NASDAQ:MGX
US Market
MGX
Metagenomi, Inc.
RESEARCH TOOLSreports

Metagenomi, Inc. (MGX) Financial Statements

Compare
976 Followers

Metagenomi, Inc. Financial Overview

Metagenomi, Inc.'s market cap is currently $49.66M. The company's EPS TTM is $-0.59; its P/E ratio is -0.69; Metagenomi, Inc. is scheduled to report earnings on March 5, 2026, and the estimated EPS forecast is $-0.55. See an overview of income statement, balance sheet, and cash flow financials.
Dec 25Dec 24Dec 23Dec 22Dec 21
Income Statement
Total Revenue$ 25.21M$ 52.30M$ 44.76M$ 17.20M$ 243.00K
Gross Profit$ 19.89M$ 52.30M$ -49.65M$ 15.47M$ -144.00K
Operating Income$ -96.01M$ -88.90M$ -78.49M$ -44.64M$ -23.95M
EBITDA$ -90.70M$ -83.49M$ -74.28M$ -39.19M$ -20.75M
Net Income$ -87.87M$ -78.06M$ -68.25M$ -43.59M$ -21.44M
Balance Sheet
Cash & Short-Term Investments$ 160.80M$ 248.31M$ 271.18M$ 362.13M$ 108.15M
Total Assets$ 221.10M$ 324.60M$ 364.84M$ 414.49M$ 141.99M
Total Debt$ 40.66M$ 45.78M$ 48.23M$ 18.57M$ 48.93M
Net Debt$ -1.06M$ 18.39M$ -92.37M$ -165.87M$ 9.63M
Total Liabilities$ 62.51M$ 89.74M$ 149.67M$ 488.91M$ 174.54M
Stockholders' Equity$ 158.60M$ 234.86M$ 215.17M$ -74.43M$ -32.54M
Cash Flow
Free Cash Flow$ -89.47M$ -112.19M$ -101.22M$ 15.75M$ 21.35M
Operating Cash Flow$ -88.89M$ -109.07M$ -91.41M$ 29.72M$ 24.26M
Investing Cash Flow$ 103.53M$ -88.16M$ 45.73M$ -122.20M$ -74.32M
Financing Cash Flow$ -356.00K$ 84.01M$ 1.01M$ 239.59M$ 39.92M
Currency in USD

Metagenomi, Inc. Earnings and Revenue History

Income Statement >

Metagenomi, Inc. Debt to Assets

Balance Sheet >

Metagenomi, Inc. Cash Flow

Cash Flow >

Metagenomi, Inc. Forecast EPS vs Actual EPS

Earnings >